Carl W. Langberg

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

Hege Sagstuen Haugnes, Torgeir Wethal, Nina Aass et al. · Journal of Clinical Oncology · 2010 · 400 citations

Medicine, Oncology, Radiation Oncology +14

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Torgrim Tandstad, Olav Dahl, Gabriella Cohn‐Cedermark et al. · Journal of Clinical Oncology · 2009 · 266 citations · Full text

Medicine, Oncology, Cancer Control +15

Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

Torgrim Tandstad, Rune Smaaland, Arne Solberg et al. · Journal of Clinical Oncology · 2011 · 230 citations · Full text

Medicine, Oncology, Chemotherapy +15

Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme

Ragnhild Helseth, Eirik Helseth, Tom Børge Johannesen et al. · Acta Neurologica Scandinavica · 2010 · 216 citations

Medicine, Oncology, Surgery +14

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Torgrim Tandstad, O. Ståhl, O. Dahl et al. · Annals of Oncology · 2014 · 155 citations · Full text

Medicine, Oncology, Immunotherapy +11